---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-008016"
form_type: "8-K"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:06:05.091591+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aditxt acquires Brain Scientific EEG assets; issues $6M Series B-1 preferred

## Summary
- Acquisition includes 16 patents and flagship NeuroCap™ and NeuroEEG™ products for neurology.
- Aditxt issued 6,000 shares of Series B-1 Convertible Preferred Stock (stated value $6M) to Brain Scientific creditors.
- Aditxt exchanged a $2.625M secured promissory note for 2,625 shares of Series B-2 Convertible Preferred Stock.
- Global EEG devices market valued at $1.06B in 2022, expected to grow at 10.2% CAGR through 2030.
- Acquired assets assigned to Pearsanta, Aditxt's majority-owned subsidiary, entering neurological diagnostics market.

## SEC filing metadata
- accession: 0001213900-24-008016
- form_type: 8-K
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390024008016/0001213900-24-008016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390024008016/ea192454-8k_aditxtinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-008016
- JSON: https://secwatch.observer/filing/0001213900-24-008016.json
- Plain text: https://secwatch.observer/filing/0001213900-24-008016.txt

## Key facts
- Material Agreements
  Aditxt, Inc. entered into Assignment and Assumption Agreement with Agent of certain secured creditors of Brain Scientific, Inc. and Philip J. von Kahle (effective 2024-01-24).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Agent of certain secured creditors of Brain Scientific, Inc. and Philip J. von Kahle
  - Effective: 2024-01-24
  source text: On January 24, 2024, Aditxt, Inc., a Delaware corporation (the “ Company ”) entered into an Assignment and Assumption Agreement (the “ Assignment Agreement ”) with the agent (the “ Agent ”) of certain secured creditors (the “ Brain Creditors ”) of Brain Scientific, Inc., a Nevada corporation (“ Brain Scientific ”) and Philip J. von Kahle (the “ Seller ”), as assignee of Brain Scientific and certain affiliated entities (collectively, the “ Brain Companies ”) under an assignment for the benefit of creditors pursuant to Chapter 727 of the Florida Statutes.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390024008016/0001213900-24-008016-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.